nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—Benzphetamine—Tamoxifen—pancreatic cancer	0.173	1	CrCrCtD
Selegiline—CYP2A6—Tamoxifen—pancreatic cancer	0.0516	0.086	CbGbCtD
Selegiline—CYP2E1—Dacarbazine—pancreatic cancer	0.0428	0.0714	CbGbCtD
Selegiline—CYP2A6—Fluorouracil—pancreatic cancer	0.038	0.0634	CbGbCtD
Selegiline—CYP2E1—Tamoxifen—pancreatic cancer	0.0341	0.0568	CbGbCtD
Selegiline—CYP2B6—Tamoxifen—pancreatic cancer	0.0336	0.056	CbGbCtD
Selegiline—CYP2B6—Irinotecan—pancreatic cancer	0.0258	0.043	CbGbCtD
Selegiline—CYP2C8—Tamoxifen—pancreatic cancer	0.0254	0.0424	CbGbCtD
Selegiline—CYP1A2—Dacarbazine—pancreatic cancer	0.0248	0.0413	CbGbCtD
Selegiline—CYP2C8—Erlotinib—pancreatic cancer	0.0216	0.0361	CbGbCtD
Selegiline—CYP2C19—Tamoxifen—pancreatic cancer	0.0213	0.0356	CbGbCtD
Selegiline—CYP1A2—Tamoxifen—pancreatic cancer	0.0197	0.0328	CbGbCtD
Selegiline—CYP2C8—Fluorouracil—pancreatic cancer	0.0187	0.0313	CbGbCtD
Selegiline—CYP2C9—Tamoxifen—pancreatic cancer	0.0177	0.0296	CbGbCtD
Selegiline—ABCB1—Tamoxifen—pancreatic cancer	0.0172	0.0287	CbGbCtD
Selegiline—CYP1A2—Erlotinib—pancreatic cancer	0.0167	0.0279	CbGbCtD
Selegiline—CYP2D6—Tamoxifen—pancreatic cancer	0.0162	0.027	CbGbCtD
Selegiline—ABCB1—Gemcitabine—pancreatic cancer	0.0148	0.0247	CbGbCtD
Selegiline—ABCB1—Erlotinib—pancreatic cancer	0.0146	0.0244	CbGbCtD
Selegiline—CYP1A2—Fluorouracil—pancreatic cancer	0.0145	0.0242	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—pancreatic cancer	0.0141	0.0235	CbGbCtD
Selegiline—CYP2D6—Erlotinib—pancreatic cancer	0.0138	0.023	CbGbCtD
Selegiline—ABCB1—Irinotecan—pancreatic cancer	0.0132	0.022	CbGbCtD
Selegiline—CYP2C9—Fluorouracil—pancreatic cancer	0.0131	0.0218	CbGbCtD
Selegiline—CYP3A4—Tamoxifen—pancreatic cancer	0.0103	0.0172	CbGbCtD
Selegiline—ABCB1—Docetaxel—pancreatic cancer	0.00969	0.0162	CbGbCtD
Selegiline—ABCB1—Sunitinib—pancreatic cancer	0.00965	0.0161	CbGbCtD
Selegiline—CYP3A4—Erlotinib—pancreatic cancer	0.00877	0.0146	CbGbCtD
Selegiline—CYP3A4—Irinotecan—pancreatic cancer	0.00792	0.0132	CbGbCtD
Selegiline—ABCB1—Doxorubicin—pancreatic cancer	0.00722	0.012	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—pancreatic cancer	0.00681	0.0113	CbGbCtD
Selegiline—CYP3A4—Docetaxel—pancreatic cancer	0.00581	0.00968	CbGbCtD
Selegiline—CYP3A4—Sunitinib—pancreatic cancer	0.00578	0.00964	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—pancreatic cancer	0.00433	0.00722	CbGbCtD
Selegiline—Asthenia—Irinotecan—pancreatic cancer	7.95e-05	0.00035	CcSEcCtD
Selegiline—Neuropathy peripheral—Epirubicin—pancreatic cancer	7.94e-05	0.00035	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	7.94e-05	0.00035	CcSEcCtD
Selegiline—Stomatitis—Epirubicin—pancreatic cancer	7.9e-05	0.000348	CcSEcCtD
Selegiline—Urinary tract infection—Epirubicin—pancreatic cancer	7.88e-05	0.000347	CcSEcCtD
Selegiline—Conjunctivitis—Epirubicin—pancreatic cancer	7.88e-05	0.000347	CcSEcCtD
Selegiline—Dysuria—Doxorubicin—pancreatic cancer	7.86e-05	0.000346	CcSEcCtD
Selegiline—Hypersensitivity—Fluorouracil—pancreatic cancer	7.82e-05	0.000345	CcSEcCtD
Selegiline—Dry mouth—Docetaxel—pancreatic cancer	7.82e-05	0.000344	CcSEcCtD
Selegiline—Sweating—Epirubicin—pancreatic cancer	7.77e-05	0.000342	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—pancreatic cancer	7.77e-05	0.000342	CcSEcCtD
Selegiline—Asthenia—Gemcitabine—pancreatic cancer	7.75e-05	0.000341	CcSEcCtD
Selegiline—Haematuria—Epirubicin—pancreatic cancer	7.73e-05	0.00034	CcSEcCtD
Selegiline—Confusional state—Docetaxel—pancreatic cancer	7.72e-05	0.00034	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—pancreatic cancer	7.67e-05	0.000338	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.66e-05	0.000338	CcSEcCtD
Selegiline—Oedema—Docetaxel—pancreatic cancer	7.66e-05	0.000338	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—pancreatic cancer	7.65e-05	0.000337	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—pancreatic cancer	7.64e-05	0.000337	CcSEcCtD
Selegiline—Pruritus—Gemcitabine—pancreatic cancer	7.64e-05	0.000336	CcSEcCtD
Selegiline—Infection—Docetaxel—pancreatic cancer	7.61e-05	0.000335	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—pancreatic cancer	7.61e-05	0.000335	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—pancreatic cancer	7.6e-05	0.000335	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.58e-05	0.000334	CcSEcCtD
Selegiline—Diarrhoea—Irinotecan—pancreatic cancer	7.58e-05	0.000334	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—pancreatic cancer	7.54e-05	0.000332	CcSEcCtD
Selegiline—Shock—Docetaxel—pancreatic cancer	7.54e-05	0.000332	CcSEcCtD
Selegiline—Nervous system disorder—Docetaxel—pancreatic cancer	7.51e-05	0.000331	CcSEcCtD
Selegiline—Pruritus—Fluorouracil—pancreatic cancer	7.51e-05	0.000331	CcSEcCtD
Selegiline—Thrombocytopenia—Docetaxel—pancreatic cancer	7.5e-05	0.00033	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—pancreatic cancer	7.5e-05	0.00033	CcSEcCtD
Selegiline—Tachycardia—Docetaxel—pancreatic cancer	7.48e-05	0.000329	CcSEcCtD
Selegiline—Skin disorder—Docetaxel—pancreatic cancer	7.44e-05	0.000328	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—pancreatic cancer	7.4e-05	0.000326	CcSEcCtD
Selegiline—Diarrhoea—Gemcitabine—pancreatic cancer	7.39e-05	0.000325	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.35e-05	0.000324	CcSEcCtD
Selegiline—Dizziness—Irinotecan—pancreatic cancer	7.33e-05	0.000323	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—pancreatic cancer	7.31e-05	0.000322	CcSEcCtD
Selegiline—Anorexia—Docetaxel—pancreatic cancer	7.3e-05	0.000322	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—pancreatic cancer	7.29e-05	0.000321	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—pancreatic cancer	7.29e-05	0.000321	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—pancreatic cancer	7.29e-05	0.000321	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—pancreatic cancer	7.27e-05	0.00032	CcSEcCtD
Selegiline—Diarrhoea—Fluorouracil—pancreatic cancer	7.26e-05	0.00032	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—pancreatic cancer	7.24e-05	0.000319	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—pancreatic cancer	7.22e-05	0.000318	CcSEcCtD
Selegiline—Sweating—Doxorubicin—pancreatic cancer	7.19e-05	0.000317	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—pancreatic cancer	7.18e-05	0.000316	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—pancreatic cancer	7.17e-05	0.000316	CcSEcCtD
Selegiline—Hypotension—Docetaxel—pancreatic cancer	7.16e-05	0.000315	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—pancreatic cancer	7.15e-05	0.000315	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—pancreatic cancer	7.13e-05	0.000314	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.09e-05	0.000312	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—pancreatic cancer	7.07e-05	0.000312	CcSEcCtD
Selegiline—Vomiting—Irinotecan—pancreatic cancer	7.05e-05	0.00031	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—pancreatic cancer	7.03e-05	0.00031	CcSEcCtD
Selegiline—Dizziness—Fluorouracil—pancreatic cancer	7.02e-05	0.000309	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—pancreatic cancer	7.01e-05	0.000309	CcSEcCtD
Selegiline—Rash—Irinotecan—pancreatic cancer	6.99e-05	0.000308	CcSEcCtD
Selegiline—Dermatitis—Irinotecan—pancreatic cancer	6.98e-05	0.000308	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.98e-05	0.000308	CcSEcCtD
Selegiline—Headache—Irinotecan—pancreatic cancer	6.94e-05	0.000306	CcSEcCtD
Selegiline—Insomnia—Docetaxel—pancreatic cancer	6.93e-05	0.000305	CcSEcCtD
Selegiline—Paraesthesia—Docetaxel—pancreatic cancer	6.88e-05	0.000303	CcSEcCtD
Selegiline—Vomiting—Gemcitabine—pancreatic cancer	6.86e-05	0.000302	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—pancreatic cancer	6.85e-05	0.000302	CcSEcCtD
Selegiline—Dyspnoea—Docetaxel—pancreatic cancer	6.83e-05	0.000301	CcSEcCtD
Selegiline—Somnolence—Docetaxel—pancreatic cancer	6.81e-05	0.0003	CcSEcCtD
Selegiline—Rash—Gemcitabine—pancreatic cancer	6.81e-05	0.0003	CcSEcCtD
Selegiline—Dermatitis—Gemcitabine—pancreatic cancer	6.8e-05	0.0003	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—pancreatic cancer	6.78e-05	0.000299	CcSEcCtD
Selegiline—Headache—Gemcitabine—pancreatic cancer	6.76e-05	0.000298	CcSEcCtD
Selegiline—Flushing—Epirubicin—pancreatic cancer	6.75e-05	0.000297	CcSEcCtD
Selegiline—Vomiting—Fluorouracil—pancreatic cancer	6.75e-05	0.000297	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—pancreatic cancer	6.75e-05	0.000297	CcSEcCtD
Selegiline—Dyspepsia—Docetaxel—pancreatic cancer	6.74e-05	0.000297	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—pancreatic cancer	6.73e-05	0.000296	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.7e-05	0.000295	CcSEcCtD
Selegiline—Rash—Fluorouracil—pancreatic cancer	6.69e-05	0.000295	CcSEcCtD
Selegiline—Dermatitis—Fluorouracil—pancreatic cancer	6.69e-05	0.000295	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—pancreatic cancer	6.68e-05	0.000294	CcSEcCtD
Selegiline—Decreased appetite—Docetaxel—pancreatic cancer	6.66e-05	0.000293	CcSEcCtD
Selegiline—Headache—Fluorouracil—pancreatic cancer	6.65e-05	0.000293	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.65e-05	0.000293	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—pancreatic cancer	6.63e-05	0.000292	CcSEcCtD
Selegiline—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.61e-05	0.000291	CcSEcCtD
Selegiline—Fatigue—Docetaxel—pancreatic cancer	6.61e-05	0.000291	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—pancreatic cancer	6.6e-05	0.000291	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—pancreatic cancer	6.6e-05	0.000291	CcSEcCtD
Selegiline—Nausea—Irinotecan—pancreatic cancer	6.58e-05	0.00029	CcSEcCtD
Selegiline—Pain—Docetaxel—pancreatic cancer	6.55e-05	0.000289	CcSEcCtD
Selegiline—Constipation—Docetaxel—pancreatic cancer	6.55e-05	0.000289	CcSEcCtD
Selegiline—Chills—Epirubicin—pancreatic cancer	6.53e-05	0.000288	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—pancreatic cancer	6.5e-05	0.000286	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—pancreatic cancer	6.49e-05	0.000286	CcSEcCtD
Selegiline—Alopecia—Epirubicin—pancreatic cancer	6.43e-05	0.000283	CcSEcCtD
Selegiline—Nausea—Gemcitabine—pancreatic cancer	6.41e-05	0.000283	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—pancreatic cancer	6.37e-05	0.000281	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—pancreatic cancer	6.33e-05	0.000279	CcSEcCtD
Selegiline—Erythema—Epirubicin—pancreatic cancer	6.33e-05	0.000279	CcSEcCtD
Selegiline—Feeling abnormal—Docetaxel—pancreatic cancer	6.31e-05	0.000278	CcSEcCtD
Selegiline—Nausea—Fluorouracil—pancreatic cancer	6.31e-05	0.000278	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—pancreatic cancer	6.27e-05	0.000276	CcSEcCtD
Selegiline—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.26e-05	0.000276	CcSEcCtD
Selegiline—Flushing—Doxorubicin—pancreatic cancer	6.25e-05	0.000275	CcSEcCtD
Selegiline—Flatulence—Epirubicin—pancreatic cancer	6.24e-05	0.000275	CcSEcCtD
Selegiline—Tension—Epirubicin—pancreatic cancer	6.21e-05	0.000274	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—pancreatic cancer	6.2e-05	0.000273	CcSEcCtD
Selegiline—Nervousness—Epirubicin—pancreatic cancer	6.15e-05	0.000271	CcSEcCtD
Selegiline—Back pain—Epirubicin—pancreatic cancer	6.12e-05	0.00027	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—pancreatic cancer	6.11e-05	0.000269	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—pancreatic cancer	6.09e-05	0.000268	CcSEcCtD
Selegiline—Body temperature increased—Docetaxel—pancreatic cancer	6.06e-05	0.000267	CcSEcCtD
Selegiline—Abdominal pain—Docetaxel—pancreatic cancer	6.06e-05	0.000267	CcSEcCtD
Selegiline—Chills—Doxorubicin—pancreatic cancer	6.04e-05	0.000266	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—pancreatic cancer	6.01e-05	0.000265	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—pancreatic cancer	5.97e-05	0.000263	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—pancreatic cancer	5.95e-05	0.000262	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—pancreatic cancer	5.9e-05	0.00026	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—pancreatic cancer	5.87e-05	0.000259	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—pancreatic cancer	5.86e-05	0.000258	CcSEcCtD
Selegiline—Erythema—Doxorubicin—pancreatic cancer	5.86e-05	0.000258	CcSEcCtD
Selegiline—Anaemia—Epirubicin—pancreatic cancer	5.85e-05	0.000258	CcSEcCtD
Selegiline—Agitation—Epirubicin—pancreatic cancer	5.82e-05	0.000256	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—pancreatic cancer	5.77e-05	0.000254	CcSEcCtD
Selegiline—Tension—Doxorubicin—pancreatic cancer	5.75e-05	0.000253	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—pancreatic cancer	5.74e-05	0.000253	CcSEcCtD
Selegiline—Malaise—Epirubicin—pancreatic cancer	5.71e-05	0.000252	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—pancreatic cancer	5.69e-05	0.000251	CcSEcCtD
Selegiline—Vertigo—Epirubicin—pancreatic cancer	5.69e-05	0.000251	CcSEcCtD
Selegiline—Syncope—Epirubicin—pancreatic cancer	5.68e-05	0.00025	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—pancreatic cancer	5.67e-05	0.00025	CcSEcCtD
Selegiline—Back pain—Doxorubicin—pancreatic cancer	5.67e-05	0.00025	CcSEcCtD
Selegiline—Hypersensitivity—Docetaxel—pancreatic cancer	5.64e-05	0.000249	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—pancreatic cancer	5.63e-05	0.000248	CcSEcCtD
Selegiline—Palpitations—Epirubicin—pancreatic cancer	5.6e-05	0.000247	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—pancreatic cancer	5.57e-05	0.000245	CcSEcCtD
Selegiline—Cough—Epirubicin—pancreatic cancer	5.53e-05	0.000243	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—pancreatic cancer	5.52e-05	0.000243	CcSEcCtD
Selegiline—Asthenia—Docetaxel—pancreatic cancer	5.5e-05	0.000242	CcSEcCtD
Selegiline—Convulsion—Epirubicin—pancreatic cancer	5.49e-05	0.000242	CcSEcCtD
Selegiline—Hypertension—Epirubicin—pancreatic cancer	5.47e-05	0.000241	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.44e-05	0.000239	CcSEcCtD
Selegiline—Pruritus—Docetaxel—pancreatic cancer	5.42e-05	0.000239	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—pancreatic cancer	5.41e-05	0.000239	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—pancreatic cancer	5.39e-05	0.000237	CcSEcCtD
Selegiline—Chest pain—Epirubicin—pancreatic cancer	5.39e-05	0.000237	CcSEcCtD
Selegiline—Myalgia—Epirubicin—pancreatic cancer	5.39e-05	0.000237	CcSEcCtD
Selegiline—Agitation—Doxorubicin—pancreatic cancer	5.38e-05	0.000237	CcSEcCtD
Selegiline—Anxiety—Epirubicin—pancreatic cancer	5.37e-05	0.000237	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.35e-05	0.000236	CcSEcCtD
Selegiline—Discomfort—Epirubicin—pancreatic cancer	5.33e-05	0.000235	CcSEcCtD
Selegiline—Malaise—Doxorubicin—pancreatic cancer	5.28e-05	0.000233	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—pancreatic cancer	5.27e-05	0.000232	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—pancreatic cancer	5.26e-05	0.000232	CcSEcCtD
Selegiline—Syncope—Doxorubicin—pancreatic cancer	5.25e-05	0.000231	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—pancreatic cancer	5.24e-05	0.000231	CcSEcCtD
Selegiline—Diarrhoea—Docetaxel—pancreatic cancer	5.24e-05	0.000231	CcSEcCtD
Selegiline—Confusional state—Epirubicin—pancreatic cancer	5.21e-05	0.00023	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—pancreatic cancer	5.18e-05	0.000228	CcSEcCtD
Selegiline—Oedema—Epirubicin—pancreatic cancer	5.17e-05	0.000228	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—pancreatic cancer	5.15e-05	0.000227	CcSEcCtD
Selegiline—Infection—Epirubicin—pancreatic cancer	5.13e-05	0.000226	CcSEcCtD
Selegiline—Cough—Doxorubicin—pancreatic cancer	5.11e-05	0.000225	CcSEcCtD
Selegiline—Shock—Epirubicin—pancreatic cancer	5.08e-05	0.000224	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—pancreatic cancer	5.08e-05	0.000224	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—pancreatic cancer	5.07e-05	0.000223	CcSEcCtD
Selegiline—Dizziness—Docetaxel—pancreatic cancer	5.07e-05	0.000223	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—pancreatic cancer	5.06e-05	0.000223	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—pancreatic cancer	5.06e-05	0.000223	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—pancreatic cancer	5.04e-05	0.000222	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—pancreatic cancer	5.02e-05	0.000221	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—pancreatic cancer	5e-05	0.00022	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—pancreatic cancer	4.99e-05	0.00022	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—pancreatic cancer	4.99e-05	0.00022	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—pancreatic cancer	4.99e-05	0.00022	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—pancreatic cancer	4.97e-05	0.000219	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.95e-05	0.000218	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—pancreatic cancer	4.93e-05	0.000217	CcSEcCtD
Selegiline—Anorexia—Epirubicin—pancreatic cancer	4.93e-05	0.000217	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—pancreatic cancer	4.88e-05	0.000215	CcSEcCtD
Selegiline—Vomiting—Docetaxel—pancreatic cancer	4.87e-05	0.000215	CcSEcCtD
Selegiline—Rash—Docetaxel—pancreatic cancer	4.83e-05	0.000213	CcSEcCtD
Selegiline—Hypotension—Epirubicin—pancreatic cancer	4.83e-05	0.000213	CcSEcCtD
Selegiline—Dermatitis—Docetaxel—pancreatic cancer	4.83e-05	0.000213	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—pancreatic cancer	4.82e-05	0.000212	CcSEcCtD
Selegiline—Headache—Docetaxel—pancreatic cancer	4.8e-05	0.000211	CcSEcCtD
Selegiline—Oedema—Doxorubicin—pancreatic cancer	4.78e-05	0.000211	CcSEcCtD
Selegiline—Infection—Doxorubicin—pancreatic cancer	4.75e-05	0.000209	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.71e-05	0.000207	CcSEcCtD
Selegiline—Shock—Doxorubicin—pancreatic cancer	4.7e-05	0.000207	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—pancreatic cancer	4.69e-05	0.000207	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.68e-05	0.000206	CcSEcCtD
Selegiline—Insomnia—Epirubicin—pancreatic cancer	4.67e-05	0.000206	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—pancreatic cancer	4.67e-05	0.000206	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—pancreatic cancer	4.64e-05	0.000205	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—pancreatic cancer	4.64e-05	0.000204	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.62e-05	0.000204	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—pancreatic cancer	4.61e-05	0.000203	CcSEcCtD
Selegiline—Somnolence—Epirubicin—pancreatic cancer	4.59e-05	0.000202	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—pancreatic cancer	4.56e-05	0.000201	CcSEcCtD
Selegiline—Nausea—Docetaxel—pancreatic cancer	4.55e-05	0.0002	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—pancreatic cancer	4.55e-05	0.0002	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—pancreatic cancer	4.49e-05	0.000198	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—pancreatic cancer	4.47e-05	0.000197	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.46e-05	0.000197	CcSEcCtD
Selegiline—Fatigue—Epirubicin—pancreatic cancer	4.46e-05	0.000196	CcSEcCtD
Selegiline—Constipation—Epirubicin—pancreatic cancer	4.42e-05	0.000195	CcSEcCtD
Selegiline—Pain—Epirubicin—pancreatic cancer	4.42e-05	0.000195	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.36e-05	0.000192	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—pancreatic cancer	4.32e-05	0.000191	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—pancreatic cancer	4.29e-05	0.000189	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—pancreatic cancer	4.26e-05	0.000188	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—pancreatic cancer	4.26e-05	0.000188	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—pancreatic cancer	4.25e-05	0.000187	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.23e-05	0.000186	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—pancreatic cancer	4.21e-05	0.000185	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—pancreatic cancer	4.16e-05	0.000183	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.13e-05	0.000182	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—pancreatic cancer	4.12e-05	0.000182	CcSEcCtD
Selegiline—Urticaria—Epirubicin—pancreatic cancer	4.11e-05	0.000181	CcSEcCtD
Selegiline—Pain—Doxorubicin—pancreatic cancer	4.09e-05	0.00018	CcSEcCtD
Selegiline—Constipation—Doxorubicin—pancreatic cancer	4.09e-05	0.00018	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—pancreatic cancer	4.09e-05	0.00018	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—pancreatic cancer	4.09e-05	0.00018	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—pancreatic cancer	3.94e-05	0.000174	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.91e-05	0.000172	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—pancreatic cancer	3.81e-05	0.000168	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—pancreatic cancer	3.8e-05	0.000167	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—pancreatic cancer	3.78e-05	0.000167	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—pancreatic cancer	3.78e-05	0.000167	CcSEcCtD
Selegiline—Asthenia—Epirubicin—pancreatic cancer	3.71e-05	0.000163	CcSEcCtD
Selegiline—Pruritus—Epirubicin—pancreatic cancer	3.66e-05	0.000161	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—pancreatic cancer	3.54e-05	0.000156	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—pancreatic cancer	3.52e-05	0.000155	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—pancreatic cancer	3.43e-05	0.000151	CcSEcCtD
Selegiline—Dizziness—Epirubicin—pancreatic cancer	3.42e-05	0.000151	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—pancreatic cancer	3.38e-05	0.000149	CcSEcCtD
Selegiline—Vomiting—Epirubicin—pancreatic cancer	3.29e-05	0.000145	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—pancreatic cancer	3.27e-05	0.000144	CcSEcCtD
Selegiline—Rash—Epirubicin—pancreatic cancer	3.26e-05	0.000144	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—pancreatic cancer	3.26e-05	0.000143	CcSEcCtD
Selegiline—Headache—Epirubicin—pancreatic cancer	3.24e-05	0.000143	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—pancreatic cancer	3.16e-05	0.000139	CcSEcCtD
Selegiline—Nausea—Epirubicin—pancreatic cancer	3.07e-05	0.000135	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—pancreatic cancer	3.04e-05	0.000134	CcSEcCtD
Selegiline—Rash—Doxorubicin—pancreatic cancer	3.01e-05	0.000133	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—pancreatic cancer	3.01e-05	0.000133	CcSEcCtD
Selegiline—Headache—Doxorubicin—pancreatic cancer	3e-05	0.000132	CcSEcCtD
Selegiline—Nausea—Doxorubicin—pancreatic cancer	2.84e-05	0.000125	CcSEcCtD
